127 related articles for article (PubMed ID: 19957084)
1. Effects of distant metastasis and peripheral CA 15-3 on the induction of spontaneous T cell responses in breast cancer patients.
Domschke C; Schuetz F; Sommerfeldt N; Rom J; Scharf A; Sohn C; Schneeweiss A; Beckhove P
Cancer Immunol Immunother; 2010 Mar; 59(3):479-86. PubMed ID: 19957084
[TBL] [Abstract][Full Text] [Related]
2. Cognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients: bidirectional cell stimulation, survival and antitumor activity in vivo.
Bai L; Beckhove P; Feuerer M; Umansky V; Choi C; Solomayer FS; Diel IJ; Schirrmacher V
Int J Cancer; 2003 Jan; 103(1):73-83. PubMed ID: 12455056
[TBL] [Abstract][Full Text] [Related]
3. Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study.
Schuetz F; Ehlert K; Ge Y; Schneeweiss A; Rom J; Inzkirweli N; Sohn C; Schirrmacher V; Beckhove P
Cancer Immunol Immunother; 2009 Jun; 58(6):887-900. PubMed ID: 18998129
[TBL] [Abstract][Full Text] [Related]
4. Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow.
Feuerer M; Beckhove P; Bai L; Solomayer EF; Bastert G; Diel IJ; Pedain C; Oberniedermayr M; Schirrmacher V; Umansky V
Nat Med; 2001 Apr; 7(4):452-8. PubMed ID: 11283672
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trial.
Domschke C; Ge Y; Bernhardt I; Schott S; Keim S; Juenger S; Bucur M; Mayer L; Blumenstein M; Rom J; Heil J; Sohn C; Schneeweiss A; Beckhove P; Schuetz F
Cancer Immunol Immunother; 2013 Jun; 62(6):1053-60. PubMed ID: 23595207
[TBL] [Abstract][Full Text] [Related]
6. High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients.
Schmitz-Winnenthal FH; Volk C; Z'graggen K; Galindo L; Nummer D; Ziouta Y; Bucur M; Weitz J; Schirrmacher V; Büchler MW; Beckhove P
Cancer Res; 2005 Nov; 65(21):10079-87. PubMed ID: 16267034
[TBL] [Abstract][Full Text] [Related]
7. Induction of antigen-specific CD4- and CD8-mediated T-cell responses by fusions of autologous dendritic cells and metastatic colorectal cancer cells.
Koido S; Hara E; Torii A; Homma S; Toyama Y; Kawahara H; Ogawa M; Watanabe M; Yanaga K; Fujise K; Gong J; Toda G
Int J Cancer; 2005 Nov; 117(4):587-95. PubMed ID: 15945098
[TBL] [Abstract][Full Text] [Related]
8. Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors.
Beckhove P; Feuerer M; Dolenc M; Schuetz F; Choi C; Sommerfeldt N; Schwendemann J; Ehlert K; Altevogt P; Bastert G; Schirrmacher V; Umansky V
J Clin Invest; 2004 Jul; 114(1):67-76. PubMed ID: 15232613
[TBL] [Abstract][Full Text] [Related]
9. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
[TBL] [Abstract][Full Text] [Related]
10. Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells.
Brossart P; Wirths S; Stuhler G; Reichardt VL; Kanz L; Brugger W
Blood; 2000 Nov; 96(9):3102-8. PubMed ID: 11049990
[TBL] [Abstract][Full Text] [Related]
11. Cancer-reactive memory T cells from bone marrow: Spontaneous induction and therapeutic potential (Review).
Schirrmacher V
Int J Oncol; 2015 Dec; 47(6):2005-16. PubMed ID: 26459860
[TBL] [Abstract][Full Text] [Related]
12. Cross-priming of cyclin B1, MUC-1 and survivin-specific CD8+ T cells by dendritic cells loaded with killed allogeneic breast cancer cells.
Saito H; Dubsky P; Dantin C; Finn OJ; Banchereau J; Palucka AK
Breast Cancer Res; 2006; 8(6):R65. PubMed ID: 17129372
[TBL] [Abstract][Full Text] [Related]
13. Generation and functional assessment of antigen-specific T cells stimulated by fusions of dendritic cells and allogeneic breast cancer cells.
Koido S; Tanaka Y; Tajiri H; Gong J
Vaccine; 2007 Mar; 25(14):2610-9. PubMed ID: 17239504
[TBL] [Abstract][Full Text] [Related]
14. Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients.
Feuerer M; Rocha M; Bai L; Umansky V; Solomayer EF; Bastert G; Diel IJ; Schirrmacher V
Int J Cancer; 2001 Apr; 92(1):96-105. PubMed ID: 11279612
[TBL] [Abstract][Full Text] [Related]
15. Paucity of functional T-cell memory to melanoma antigens in healthy donors and melanoma patients.
Dhodapkar MV; Young JW; Chapman PB; Cox WI; Fonteneau JF; Amigorena S; Houghton AN; Steinman RM; Bhardwaj N
Clin Cancer Res; 2000 Dec; 6(12):4831-8. PubMed ID: 11156242
[TBL] [Abstract][Full Text] [Related]
16. Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers.
Bohnenkamp HR; Coleman J; Burchell JM; Taylor-Papadimitriou J; Noll T
Cell Immunol; 2004; 231(1-2):112-25. PubMed ID: 15919376
[TBL] [Abstract][Full Text] [Related]
17. The shaping of a polyvalent and highly individual T-cell repertoire in the bone marrow of breast cancer patients.
Sommerfeldt N; Schütz F; Sohn C; Förster J; Schirrmacher V; Beckhove P
Cancer Res; 2006 Aug; 66(16):8258-65. PubMed ID: 16912206
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial.
Baek S; Kim CS; Kim SB; Kim YM; Kwon SW; Kim Y; Kim H; Lee H
J Transl Med; 2011 Oct; 9():178. PubMed ID: 22013914
[TBL] [Abstract][Full Text] [Related]
20. Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients.
Bercovici N; Haicheur N; Massicard S; Vernel-Pauillac F; Adotevi O; Landais D; Gorin I; Robert C; Prince HM; Grob JJ; Leccia MT; Lesimple T; Wijdenes J; Bartholeyns J; Fridman WH; Salcedo M; Ferries E; Tartour E
J Immunother; 2008 Jan; 31(1):101-12. PubMed ID: 18157017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]